Skip To Main Content
Jianmin Fang on Muck Rack

Jianmin Fang

China
As seen in: Nature, MDPI, The New England Journal of Medicine, BioRxiv
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Jianmin

Contact Jianmin, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Disitamab vedotin for HER2-positive breast cancer with liver metastases: phase 3 results from the RC48-C006 phase 2/3 trial

|
By Jiayu Wang, Quchang Ouyang, Weimin Xie, Zhaofeng Niu, Qingyuan Zhang, Jianying Chang, Ying Cheng, Airong Wang, Jingfen Wang, Herui Yao, Tao Lin Sun, Zhongsheng Tong, Xinhong Wu, Yongsheng Wang, Enxiang Zhou, Xiangshun Kong, De Zeng, Shanshan Gu, Yanyan Hou, Dandan Gao, Jianmin Fang, Binghe Xu, Yue’e Teng, Zhuangqing Yang, Xujuan Wang, Zerui Qu, Chenran Han
| Nature Verified
Abstract Patients with HER2-positive advanced breast cancer with liver metastases (BCLM) have poor prognosis. Study RC48-C006 is a prospective, open-label, multi-center, randomized phase 2/3 trial (ClinicalTrials.gov identifier, NCT03500380). Based on the phase 2 results, the phase 3 stage was initiated to evaluate disitamab vedotin (DV) versus lapatinib plus capecitabine (L + C) in patients with HER2-positive BCLM who were previously treated with trastuzumab and taxanes.
Open in Who Shared Issue with article?

A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus | NEJM

|
By Li Wang, Jianmin Fang, Fengchun Zhang
| The New England Journal of Medicine Verified
Notes A data sharing statement provided by the authors is available with the full text of this article at NEJM.org. Supported by RemeGen. Disclosure forms provided by the authors are available with the full text of this article at NEJM.org. We thank the trial participants, coordinators, and staff for their contributions to the trial.
Open in Who Shared Issue with article?

Animals | Free Full-Text | Effects of Supplementation with Oregano Essential Oil during Late Gestation and Lactation on Serum Metabolites, Antioxidant Capacity and Fecal Microbiota of Sows

|
By Yuanyi Zhang, Yuhang Deng, Yubin Hao, Jianmin Fang
| MDPI
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Open in Who Shared Issue with article?
See all 4 articles